Search Results - "Falci, Diego"
-
1
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Published in The New England journal of medicine (18-11-2021)“…In this ongoing, randomized, phase 3 trial, sotrovimab (a SARS-CoV-2–targeted monoclonal antibody) or placebo was administered to outpatients within 5 days…”
Get full text
Journal Article -
2
Neglected endemic mycoses
Published in The Lancet infectious diseases (01-11-2017)“…Fungi often infect mammalian hosts via the respiratory route, but traumatic transcutaneous implantation is also an important source of infections…”
Get full text
Journal Article -
3
Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
Published in Clinical infectious diseases (15-08-2013)“…Background. Polymyxin B is a last-line therapy for multidrug-resistant gram-negative bacteria. There is a dearth of pharmacokinetic data to guide dosing in…”
Get full text
Journal Article -
4
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (05-04-2022)“…IMPORTANCE: Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a…”
Get full text
Journal Article -
5
Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities
Published in Mycoses (01-04-2019)“…Summary Despite the existence of endemic mycoses in Latin America and the Caribbean, in addition to a large population of patients at risk for invasive…”
Get full text
Journal Article -
6
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
Published in Antibiotics (Basel) (14-03-2019)“…Polymyxins are valuable antimicrobials for the management of multidrug-resistant Gram-negative bacteria; however, nephrotoxicity associated with these drugs is…”
Get full text
Journal Article -
7
Clinical Characteristics of Covid-19 in China
Published in The New England journal of medicine (07-05-2020)“…To the Editor: According to the World Health Organization (WHO), the case definition for surveillance of returning travelers requires that they need to present…”
Get full text
Journal Article -
8
Single-Dose Amphotericin B for Cryptococcal Meningitis
Published in The New England journal of medicine (28-07-2022)“…To the Editor: Jarvis et al. (March 24 issue) 1 showed that a regimen that included a single dose of liposomal amphotericin B (10 mg per kilogram of body…”
Get full text
Journal Article -
9
Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B
Published in Antimicrobial agents and chemotherapy (01-01-2018)“…The use of very high doses of polymyxin B (PMB) against carbapenem-resistant Gram-negative bacilli has been addressed in experiments as a strategy to improve…”
Get full text
Journal Article -
10
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Published in Antimicrobial agents and chemotherapy (01-04-2016)“…Nephrotoxicity is the main adverse effect of colistin and polymyxin B (PMB). It is not clear whether these two antibiotics are associated with different…”
Get full text
Journal Article -
11
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
Published in Infection and drug resistance (22-10-2013)“…The triazole class of antifungal drugs comprises first-line agents for the treatment of several invasive fungal diseases. Isavuconazole is a novel…”
Get full text
Journal Article -
12
Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: A systematic review and meta-analysis
Published in Medicine (Baltimore) (08-12-2023)“…Immunobiological drugs such as TNF-α inhibitors are valuable in rescue therapy for autoimmune diseases such as rheumatoid arthritis and inflammatory bowel…”
Get full text
Journal Article -
13
Early antiretroviral therapy for HIV-infected patients admitted to an intensive care unit (EARTH-ICU): A randomized clinical trial
Published in PloS one (21-09-2020)“…Background Highly active antiretroviral therapy (HAART) has reduced HIV-related morbidity and mortality at all stages of infection and reduced transmission of…”
Get full text
Journal Article -
14
Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
Published in Journal of antimicrobial chemotherapy (01-05-2015)“…The objectives of this study were to assess risk factors for acute kidney injury (AKI) in patients treated with polymyxin B, a last resort antibiotic against…”
Get full text
Journal Article -
15
Single High Dose of Liposomal Amphotericin B in Human Immunodeficiency Virus/AIDS-Related Disseminated Histoplasmosis: A Randomized Trial
Published in Clinical infectious diseases (13-10-2023)“…Abstract Background Histoplasmosis is a major AIDS-defining illness in Latin America. Liposomal amphotericin B (L-AmB) is the drug of choice for treatment, but…”
Get full text
Journal Article -
16
In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016–2020
Published in Journal of global antimicrobial resistance. (01-03-2024)“…•Strong activity for ceftaroline against MRSA (MIC90 1–2 mg/L) from SSTIs and RTIs.•Higher susceptibility to ceftaroline for MRSA from SSTIs versus RTIs (92.5%…”
Get full text
Journal Article -
17
Impact of polymyxin-B-associated acute kidney injury in 1-year mortality and renal function recovery
Published in International journal of antimicrobial agents (01-07-2018)“…•46.1% of patients who survived the first 30 days after PMB died within 1 year.•Renal failure and dialyses during PMB therapy were related to 1-year…”
Get full text
Journal Article -
18
Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
Published in Mycoses (01-02-2015)“…Summary Amphotericin B (AmB) use is limited by the occurrence of kidney toxicity. Here, we evaluated the incidence and impact of nephrotoxicity in a large…”
Get full text
Journal Article -
19
The current state of Clinical Mycology in Eastern and South-Eastern Europe
Published in Medical mycology (Oxford) (22-03-2022)“…Abstract The ability of medical centers in Eastern and South-Eastern Europe to diagnose and treat fungal infections remains unknown. In order to investigate…”
Get full text
Journal Article -
20
Hematological toxicities associated with amphotericin B formulations
Published in Leukemia & lymphoma (03-10-2015)“…Even though amphotericin B is associated with considerable hematological toxicity, this subject has been poorly studied. This retrospective cohort study…”
Get full text
Journal Article